Century Therapeutics Inc. Watch

EX-10.3

from 10-Q 4 pages Century Therapeutics, Inc. 2021 Equity Incentive Plan Performance-Based Restricted Stock Unit Grant Notice and Award Agreement

12/34/56

EX-10.2

from 10-Q 10 pages Executive Employment Agreement

12/34/56

EX-10.1

from 10-Q 11 pages ​ Executive Employment Agreement

12/34/56

EX-10.2

from 8-K 13 pages Registration Rights Agreement

12/34/56

EX-10.1

from 8-K 23 pages Securities Purchase Agreement

12/34/56

EX-10.40

from 10-K 29 pages [***] Certain Information in This Document Has Been Excluded Pursuant to Regulation S-K, Item 601(b)(10). Such Excluded Information Is Not Material and the Registrant Customarily and Actually Treats as Private and Confidential. License Agreement

12/34/56

EX-10.35

from 10-K 8 pages Executive Employment Agreement ​

12/34/56

EX-10.3

from 10-Q 4 pages Second Amendment to License Agreement

12/34/56

EX-10.2

from 10-Q 4 pages Amendment No. 5 to Master Collaboration Agreement

12/34/56

EX-10.1

from 10-Q 5 pages Second Amendment to License Agreement

12/34/56

EX-10.2

from 10-Q 10 pages ​ Separation Agreement and Release

12/34/56

EX-10.1

from 10-Q 9 pages ​ Executive Employment Agreement

12/34/56

EX-10.1

from 8-K/A 7 pages April 28, 2023 Personal and Confidential Osvaldo Flores, Phd Re: Separation Agreement ● Pay You Salary Accrued to You Through Your Last Day of Employment With the Company; ● Provide You With Information on How to Continue Your Healthcare Coverage Through the Consolidated Omnibus Budget Reconciliation Act of 1985 (“Cobra”); and ● Reimburse You for Any Outstanding, Reasonable Business Expenses That You Have Incurred on the Company’s Behalf Through the Termination of Your Employment, After the Company’s Timely Receipt of Appropriate Documentation Pursuant to the Company’s Business Expense Reimbursement Policy

12/34/56

EX-10.1

from 8-K 3 pages Side Letter to Executive Employment Agreement

12/34/56

EX-10.1

from 10-Q 4 pages Amendment No. 4 to Master Collaboration Agreement ​ ​

12/34/56

EX-10.31

from 10-K 85 pages [***] Certain Information in This Document Has Been Excluded Pursuant to Regulation S-K, Item 601(b)(10). Such Excluded Information Is Not Material and the Registrant Customarily and Actually Treats as Private and Confidential. Research Collaboration and License Agreement

12/34/56

EX-10.25

from 10-K 9 pages ​ [***] Certain Information in This Document Has Been Excluded Pursuant to Regulation S- K, Item 601(b)(10). Such Excluded Information Is Not Material and the Registrant Customarily and Actually Treats as Private and Confidential. ​

12/34/56

EX-10.1

from 8-K 18 pages Securities Purchase Agreement

12/34/56

EX-10.23

from S-1/A 35 pages Article 1 Definitions

12/34/56

EX-10.21

from S-1/A 36 pages [***] Certain Information in This Document Has Been Excluded Pursuant to Regulation S-K, Item 601(b)(10). Such Excluded Information Is Not Material and the Registrant Customarily and Actually Treats as Private and Confidential. License Agreement

12/34/56